IPO Boutique

Aratana Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Aratana Therapeutics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Aratana TherapeuticsPETX - $11.00-$13.00 $6.00 $7.005.75 million6/27/2013
Stifel, Lazard Capital
Co-Manager(s):
William Blair, JMP Securities, Craig-Hallum Capital Group
Health Care
Filing(s):

Filed 2013-03-20



Aratana Therapeutics Quote & Chart - Click for current quote - PETX

About Aratana Therapeutics (adapted from Aratana Therapeutics prospectus):
They are a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics.

This description is adapted from Aratana PETX prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Aratana PETX "PETX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved